Correction to: The role of melatonin in the onset and progression of type 3 diabetes.

CORRECTION TO: MOLECULAR BRAIN (2017) 10:35 DOI: 10.1186/S13041-017-0315-X: In the original version of this article [1], published on 1 August 2017, Fig. 3 contains a typo. In this Correction the incorrect and correct version of Fig. 3 are shown. - Fig. 3 was originally published like this: - The correct version of Fig. 3 looks like this.

Correction to: Molecular Brain (2017) 10:35 DOI: 10.1186/s13041-017-0315-x

In the original version of this article [1], published on 1 August 2017, Fig. 3 contains a typo. In this Correction the incorrect and correct version of Fig. 3 are shown.

Fig. 3

Melatonin restores the disruption of insulin signaling in AD. In insulin resistance condition, melatonin activates PI3K/Akt signaling, leading to the decrease of tau hyperphosphorylation and Aβ accumulation

Figure 3 was originally published like this:

The correct version of Fig. 3 looks like this:

Fig. 3

Melatonin restores the disruption of insulin signaling in AD. In insulin resistance condition, melatonin activates PI3K/Akt signaling, leading to the decrease of tau hyperphosphorylation and Aβ accumulation